Literature DB >> 24131187

TREM2 and neurodegenerative disease.

Bruno A Benitez, Carlos Cruchaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24131187      PMCID： PMC4380008          DOI： 10.1056/NEJMc1306509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  TREM2 is associated with the risk of Alzheimer's disease in Spanish population.

Authors:  Bruno A Benitez; Breanna Cooper; Pau Pastor; Sheng-Chih Jin; Elena Lorenzo; Sebastian Cervantes; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-02-05       Impact factor: 4.673

2.  Parkinson disease is not associated with C9ORF72 repeat expansions.

Authors:  Matthew B Harms; Drexel Neumann; Bruno A Benitez; Breanna Cooper; David Carrell; Brad A Racette; Joel S Perlmutter; Alison Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2012-10-30       Impact factor: 4.673

3.  A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia.

Authors:  Christine L Hsieh; Maya Koike; Steve C Spusta; Erene C Niemi; Midori Yenari; Mary C Nakamura; William E Seaman
Journal:  J Neurochem       Date:  2009-03-19       Impact factor: 5.372

4.  Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.

Authors:  Carlos Cruchaga; Gabe Haller; Sumitra Chakraverty; Kevin Mayo; Francesco L M Vallania; Robi D Mitra; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Pamela St Jean; Michael Lawson; Margaret G Ehm; Richard Mayeux; Alison M Goate
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

5.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245
  5 in total
  50 in total

1.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

Authors:  Laura Piccio; Yuetiva Deming; Jorge L Del-Águila; Laura Ghezzi; David M Holtzman; Anne M Fagan; Chiara Fenoglio; Daniela Galimberti; Barbara Borroni; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2016-01-11       Impact factor: 17.088

2.  Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.

Authors:  Jerel Adam Fields; Brian Spencer; Mary Swinton; Emma Martine Qvale; María J Marquine; Arina Alexeeva; Sarah Gough; Benchawanna Soontornniyomkij; Elvira Valera; Eliezer Masliah; Cristian L Achim; Paula Desplats
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

3.  TREM2 regulates microglial cell activation in response to demyelination in vivo.

Authors:  Claudia Cantoni; Bryan Bollman; Danilo Licastro; Mingqiang Xie; Robert Mikesell; Robert Schmidt; Carla M Yuede; Daniela Galimberti; Gunilla Olivecrona; Robyn S Klein; Anne H Cross; Karel Otero; Laura Piccio
Journal:  Acta Neuropathol       Date:  2015-01-29       Impact factor: 17.088

4.  Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.

Authors:  Elkin O Luis; Sara Ortega-Cubero; Isabel Lamet; Cristina Razquin; Carlos Cruchaga; Bruno A Benitez; Elena Lorenzo; Jaione Irigoyen; Maria A Pastor; Pau Pastor
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

5.  Preparation, crystallization, and preliminary crystallographic analysis of wild-type and mutant human TREM-2 ectodomains linked to neurodegenerative and inflammatory diseases.

Authors:  Daniel L Kober; Kelsey M Wanhainen; Britney M Johnson; David T Randolph; Michael J Holtzman; Tom J Brett
Journal:  Protein Expr Purif       Date:  2014-02-07       Impact factor: 1.650

6.  Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.

Authors:  Carlos Cruchaga; Jorge L Del-Aguila; Benjamin Saef; Kathleen Black; Maria Victoria Fernandez; John Budde; Laura Ibanez; Yuetiva Deming; Manav Kapoor; Giuseppe Tosto; Richard P Mayeux; David M Holtzman; Anne M Fagan; John C Morris; Randall J Bateman; Alison M Goate; Oscar Harari
Journal:  Alzheimers Dement       Date:  2017-09-21       Impact factor: 21.566

Review 7.  Essential tremor.

Authors:  Lorraine N Clark; Elan D Louis
Journal:  Handb Clin Neurol       Date:  2018

8.  TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.

Authors:  Ying Guo; Xinbing Wei; Hua Yan; Yue Qin; Shaoqi Yan; Jia Liu; Yong Zhao; Fan Jiang; Haiyan Lou
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

9.  Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson's Disease Susceptibility.

Authors:  Guiyou Liu; Yongquan Liu; Qinghua Jiang; Yongshuai Jiang; Rennan Feng; Liangcai Zhang; Zugen Chen; Keshen Li; Jiafeng Liu
Journal:  Mol Neurobiol       Date:  2015-09-14       Impact factor: 5.590

10.  Assessment of TREM2 rs75932628 association with Parkinson's disease and multiple system atrophy in a Chinese population.

Authors:  Yongping Chen; Xueping Chen; Xiaoyan Guo; Wei Song; Bei Cao; Qianqian Wei; Ruwei Ou; Bi Zhao; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2015-06-10       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.